Monoclonal gammopathy of undetermined significance

Current Topics in Microbiology and Immunology

Volumn 210, Issue , 1996, Pages 375-383

  Kyle, R A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; SILICONE;

ADULT; AMYLOIDOSIS; BREAST PROSTHESIS; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PRIORITY JOURNAL; SILICONE PROSTHESIS;

EID: 0030052010     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85226-8_40     Document Type: Conference Paper

References (18)

1. Axelsson U (1986) A 20-year follow up study of 64 subjects with M-components. Acta Med 219:519-522
2. Axelsson U, Bachman R, Hällén J (1966) Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 179:235-247
3. Belisle LM, Case DC Jr & Neveux L (1990) Quantitation of risk of malignant transformation in patients with "benign" monoclonal gammopathy (BMG) (Abstract). Blood 76(Suppl 1):342a
4. Bladé J, Lopez-Guillermo A, Rozman C et al (1992) Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 81:391-394
5. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton III LJ (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330:1697-1702
6. Giraldo MP, Rubio-Félix D, Perella M et al (1991) Aspectos clinicos, biológicos y evolutivos de 397 casos. Sangre 36:377-382
7. Kyle RA (1993) "Benign" monoclonal gammopathy - after 20 to 35 years of follow up Mayo Clin Proc 68:26-36
8. Kyle RA (1994) The monoclonal gammopathies. Clin Chem 40:2154-2161
9. Kyle RA, : Finkelstein S, Elveback LR, Kurland LT (1972) Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 40:719-724
10. Kyle RA, Beard CM, O'Fallon WM, Kurland LT (1994) Incidence of multiple myeloma in Olmsted County, Minnesota 1978 through 1990, with a review of the trend since 1945. J Clin Oncol 12:1577-1583
11. Kyle RA, Greipp PR (1980) Series on clinical testing. 3. The laboratory investigation of monoclonal gammopathies. Mayo Clin Proc 53:719-739
12. Miller BA, Ries LA, Hankey BF, et al (1993) SEER Cancer Statistics Review 1973-1990. NIH Publ No. 93-2789, Bethesda, Maryland: NCI
13. Patadini G, Fogher M, Mazzanti G et al (1989) Idiopathic monoclonal gammopathy: long-term study of 313 cases. Recent Prog 80:123-132
14. Potter M, Morrison S, Wiener F, Zhang XK, Miller FW (1994) Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst 86:1058-1065
15. Saleun JP, Vicariot M, Deroff P (1982) Monoclonal gammopathies in the adult population of Finistère, France J Clin Pathol 35:63-68
16. Salmon SE, Kyle RA (1994) Silicone gels, induction of plasma cell tumors, and genetic susceptibility in mice: a call for epidemiologic investigation of women with silicone breast implants. J Natl Cancer Inst 86:1042-1041
17. Witzig TE, Kyle RA & Greipp PR (1992) Circulating peripheral blood plasma cells in multiple myeloma. Curr Topics Microbiol Immunol 182:195-199
18. Witzig TE, Kyle RA, O'Fallon WM & Greipp PR (1994) Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol 87:266-272